$33.0M
The Cambridge wound care company raised the Series C financing from existing backers to fund US market expansion and product reimbursement.
Inotec develops wearable continuous topical oxygen therapy devices for chronic wound care.
Cambridge-based medical technology company developing continuous topical oxygen therapy devices to treat hard-to-heal chronic wounds.
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Current assets
Cash, assets and headcount from Inotec's latest Companies House filing — with year-on-year movement, free with a Winfred account.
The Cambridge wound care company raised the Series C financing from existing backers to fund US market expansion and product reimbursement.